Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Osny

10 clinical trials in Osny, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Osny at a glance
10
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Osny

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ivonescimab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cabazitaxel
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Osny

What the registry says about research in the country

01 Prostate Cancer Research

Innovative clinical trials focusing on high-risk localized prostate cancer, combining advanced treatment modalities including intravenous therapy and radiation treatment approaches.

  • Combination therapy evaluation
  • Radiation treatment optimization
  • Hormone therapy integration

Research aims to improve progression-free survival rates in high-risk patients.

02 Head and Neck Cancer Studies

Multiple trials investigating novel treatments for squamous cell carcinoma of the head and neck, exploring combinations of immunotherapy with standard treatments.

  • Immunotherapy combinations
  • Radiotherapy enhancement
  • Treatment optimization

Studies focus on improving survival outcomes through innovative therapeutic approaches.

03 Breast Cancer Innovation

Groundbreaking research in HER2-positive metastatic breast cancer treatment, exploring potential de-escalation strategies based on molecular monitoring.

  • Treatment de-escalation
  • Blood-based monitoring
  • Targeted therapy optimization

Research aims to personalize treatment duration based on disease response.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.